Research Article

Live Microalgae-Based Diets as Enrichment to Improve the Nutritional Profile of the Calanoid Copepod Acartia tonsa (Dana, 1849) Nauplii

Table 5

Proximal composition (lipid, protein, carbohydrate, ash, and moisture content; g/100 g dry weight) and fatty acid composition (mg/g dry weight) of copepods (A. tonsa) nauplii, fed with three microalgae diets (R, Rhodomonas salina; I–R, Isochrysis galbana + Rhodomonas salina; T–R, Tetraselmis suecica + Rhodomonas salina), n = 5.

Acartia tonsaT–RI–RR

Lipids18.0 ± 0.3b16.4 ± 0.5a15.9 ± 0.3a
Proteins71.8 ± 0.7b70.7 ± 0.7b68.1 ± 0.6a
Carbohydrates4.0 ± 0.4a6.4 ± 0.6b9.1 ± 0.6c
Ash6.3 ± 0.46.6 ± 0.66.9 ± 0.2
Moisture7.2 ± 0.77.6 ± 0.68.4 ± 0.7
14 : 00.4 ± 0.10.5 ± 0.10.5 ± 0.2
14 : 1n-50.1 ± 0.00.1 ± 0.10.1 ± 0.1
16 : 03.8 ± 0.4c1.2 ± 0.2a2.5 ± 0.3b
16 : 1n-70.6 ± 0.50.2 ± 0.00.2 ± 0.0
16 : 3n-10.2 ± 0.0
18 : 01.3 ± 0.1b0.7 ± 0.1a1.4 ± 0.2b
18 : 1n-91.3 ± 0.3b0.7 ± 0.1a0.6 ± 0.2a
18 : 1n-70.6 ± 0.1b0.3 ± 0.0a0.4 ± 0.1a
18 : 2n-60.7 ± 0.1b0.4 ± 0.1a0.2 ± 0.1a
18 : 3n-60.1 ± 0.0
18 : 3n-31.8 ± 0.2b1.0 ± 0.1a1.2 ± 0.1a
18 : 4n-30.7 ± 0.20.5 ± 0.10.4 ± 0.1
20 : 1n-50.2 ± 0.10.1 ± 0.0
20 : 2n-60.1 ± 0.00.1 ± 0.0
20 : 4n-6 ARA0.2 ± 0.0b0.1 ± 0.0a0.1 ± 0.0a
20 : 3n-30.1 ± 0.00.1 ± 0.00.1 ± 0.0
20 : 4n-30.2 ± 0.10.1 ± 0.00.1 ± 0.1
20 : 5n-3 EPA2.9 ± 0.3ab2.9 ± 0.1b2.5 ± 0.1a
22 : 1n-110.1 ± 0.0
22 : 5n-30.1 ± 0.00.1 ± 0.00.2 ± 0.1
22 : 6n-3 DHA2.1 ± 0.3a6.7 ± 0.2c4.6 ± 0.2b
Σn-317.8 ± 0.8a11.5 ± 0.3c9.2 ± 0.4b
Σn-621.1 ± 0.2c0.7 ± 0.2b0.4 ± 0.1a
Σn-931.5 ± 0.3b0.8 ± 0.1a0.8 ± 0.1a
ΣSAFAs45.6 ± 0.5b2.5 ± 0.1a4.6 ± 0.4b
ΣMUFAs53.2 ± 0.6b1.5 ± 0.1a1.7 ± 0.2a
Σn-3 LC-PUFAs65.3 ± 0.5a9.9 ± 0.2c7.6 ± 0.4b
ratio n-3/n-67.2 ± 1.7a17.2 ± 3.7b24.5 ± 5.0b
ratio n-3/n-95.5 ± 0.9a14.7 ± 2.0b12.2 ± 2.1b
ratio n-6/n-90.8 ± 0.20.9 ± 0.40.5 ± 0.1
ratio DHA/EPA0.7 ± 0.1a2.3 ± 0.1c1.9 ± 0.1b
ratio DHA/ARA12.2 ± 3.2a96.8 ± 5.0c80.9 ± 6.7b
ratio EPA/ARA16.7 ± 3.6a42.0 ± 2.7b43.6 ± 3.2b

Values (mean ± SD) followed by different superscripts within a row were () significantly different among the three treatments. n, number of replicates; SAFA, saturated fatty acid; MUFA, monounsaturated fatty acid; LC-PUFA, long-chain polyunsaturated fatty acid; DHA, docosahexanoic acid; EPA, eicosapentanoic acid; ARA, arachidonic acid. 1Includes 16 : 3n-3, 16 : 4n-3, 18 : 3n-3, 18 : 4n-3, 20 : 3n-3, 20 : 4n-3, 20 : 5n-3, 22 : 5n-3, and 22 : 6n-3. 2Includes 16 : 2n-6, 18 : 2n-6, 18 : 3n-6, 20 : 2n-6, 20 : 3n-6, 20 : 4n-6, 22 : 4n-6 and 22 : 5n-6. 3Includes 18 : 1n-9, 18 : 2n-9, 20 : 1n-9, 20 : 2n-9, 20 : 3n-9 and 22 : 1n-9. 4 Includes 14 : 0, 15 : 0, 16 : 0, 17 : 0, 18 : 0, and 20 : 0. 5Includes 14 : 1n-5, 14 : 1n-7, 15 : 1n-5, 16 : 1n-7, 16 : 1n-5, 18 : 1n-9, 18 : 1n-7, 18 : 1n-5, 20 : 1n-9, 20 : 1n-7, 20 : 1n-5, 22 : 1n-9 and 22 : 1n-11. 6Includes 20 : 3n-3, 20 : 4n-3, 20 : 5n-3, 22 : 5n-3, and 22 : 6n-3.